Literature DB >> 32739762

Wilms' tumor (WT1) (±KTS) variants decreases the progesterone secretion of bovine ovarian theca cells.

X Wang1, K Meng2, Y Wang1, Y Zhao1, F Lin1, X Liu1, Y Zhang3, F Quan4.   

Abstract

Wilms' tumor gene WT1 encodes a nuclear transcriptional factor, which has been shown to regulate granulosa cell steroidogenesis in bovine; however, it is not known whether the functions of theca cells are regulated by WT1. Here, we determined the effects of this gene on theca cell proliferation, apoptosis, and steroidogenesis in vitro. In cultured bovine theca cells, the downregulation of WT1 increased the secretion of progesterone but had no effect on proliferation and apoptosis. WT1 includes the variants WT1(+KTS) and WT1(-KTS), which differ by 3 amino acids KTS (lysine, threonine, and serine). WT1(±KTS) upregulation increased the messenger RNA (mRNA) expression of STAR and CYP17A1 and decreased the progesterone secretion and CYP11A1 mRNA expression. In contrast to WT1(+KTS), WT1(-KTS) upregulation also decreased the mRNA expression of 3β-HSD. In both variants, WT1(-KTS) has more obvious effects. In conclusion, WT1 can decrease progesterone secretion, likely due in part to the inhibition of CYP11A1 and 3β-HSD.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bovine; Progesterone; Theca cell; WT1(+KTS); WT1(−KTS)

Year:  2020        PMID: 32739762     DOI: 10.1016/j.domaniend.2020.106521

Source DB:  PubMed          Journal:  Domest Anim Endocrinol        ISSN: 0739-7240            Impact factor:   2.290


  2 in total

1.  Whole exome sequencing identified a rare WT1 loss-of-function variant in a non-syndromic POI patient.

Authors:  Yingchen Wang; Qing Chen; Feng Zhang; Xi Yang; Lingyue Shang; Shuting Ren; Yuncheng Pan; Zixue Zhou; Guoqing Li; Yunzheng Fang; Li Jin; Yanhua Wu; Xiaojin Zhang
Journal:  Mol Genet Genomic Med       Date:  2021-11-29       Impact factor: 2.183

2.  Pyrvinium pamoate can overcome artemisinin's resistance in anaplastic thyroid cancer.

Authors:  Yitian Li
Journal:  BMC Complement Med Ther       Date:  2021-05-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.